Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion.
Casali
C
C
Laboratoire Creatis (UMR CNRS 5515), Hopital Cardiologique, Lyon, France.
Janier
M
M
Canet
E
E
Obadia
J F
JF
Benderbous
S
S
Corot
C
C
Revel
D
D
D000818:Animals; D003287:Contrast Media; D003326:Coronary Circulation / Q000502:physiology*; D005682:Gadolinium; D006571:Heterocyclic Compounds; D066298:In Vitro Techniques; D008279:Magnetic Resonance Imaging; D008536:Meglumine / Q000031:analogs & derivatives*; D009942:Organometallic Compounds; D013552:Swine
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C107329:carboxymethyl-dextran-A2-gadolinium-DOTA; C112669:gadolinium DOTA meglumine; D008536:Meglumine; D005682:Gadolinium